Dr. Lavanya Mittal, MD

Dr. Mittal practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Mittal's NPI, 1528563509, was assigned on March 29, 2018. Dr. Mittal graduated from Albert Einstein College of Medicine in 2017. Dr. Mittal holds New York license 315224.

Dr. Mittal's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Mittal's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Dermatology Group. Dmand AI also links Dr. Mittal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittal practices. Vendor and product names are available with a free account.

Dermatology is Dr. Mittal's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mittal is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mittal's licenses on file in 2 states: New York and New Jersey.

CMS data shows 240 Medicare services from Dr. Mittal across 5 procedure codes in 2024, for 186 Medicare patients. Medicare paid $22,806 for them.

CMS counts 186 Medicare patients who saw Dr. Mittal in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mittal's median patient age at 71, with 61% women.

In 2024, Dr. Mittal wrote 273 Medicare Part D claims for 94 patients. 93% of them were for generic drugs. CMS names the drug for 165 of them, across 6 drugs with 11 or more claims each, at $7,123 in total drug cost. In 2022, CMS named 132 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mittal for performance year 2024, reported as part of a group. Dr. Mittal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mittal as offering telehealth. CMS counts 17 procedures of skin biopsy by Dr. Mittal, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Mittal, published from 2017 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Dermatomyositis, Antimalarials and Comorbidity. Dr. Mittal has published most often in J Am Acad Dermatol. Dr. Mittal's most frequent co-authors are Alisa Nicole Femia, MD, Victoria P. Werth, MD and Eva R. Parker, MD.

CMS Open Payments shows 48 general payments to Dr. Mittal from 12 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $522.

Dr. Mittal graduated from Albert Einstein College of Medicine in 2017.

Dr. Mittal is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Cigna. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.